MEX:MDTN (Ireland)
Business Description
Medtronic PLC
NAICS : 334510
SIC : 3845
Compare
Compare
Traded in other countries / regions
MDT.Argentina
•
MDT.Austria
•
MDTC34.Brazil
•
2M6.Germany
•
MDTN.Mexico
•
MDT.Switzerland
•
0Y6X.UK
•
MDT.USA
Description
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.38 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.44 | |||||
| Debt-to-EBITDA | 2.58 | |||||
| Interest Coverage | 10.59 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.93 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.4 | |||||
| 3-Year EBITDA Growth Rate | -1.8 | |||||
| 3-Year EPS without NRI Growth Rate | 3 | |||||
| 3-Year FCF Growth Rate | 0.7 | |||||
| 3-Year Book Growth Rate | 1.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 5.98 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 3.41 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.89 | |||||
| 9-Day RSI | 3.17 | |||||
| 14-Day RSI | 5.76 | |||||
| 6-1 Month Momentum % | -15.49 | |||||
| 12-1 Month Momentum % | -26.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.58 | |||||
| Quick Ratio | 1.23 | |||||
| Cash Ratio | 0.63 | |||||
| Days Inventory | 163.77 | |||||
| Days Sales Outstanding | 63.98 | |||||
| Days Payable | 74.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.27 | |||||
| Dividend Payout Ratio | 0.66 | |||||
| 3-Year Dividend Growth Rate | 8 | |||||
| Forward Dividend Yield % | 3.36 | |||||
| 5-Year Yield-on-Cost % | 4.8 | |||||
| 3-Year Average Share Buyback Ratio | 0.2 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.61 | |||||
| Operating Margin % | 19.79 | |||||
| Net Margin % | 16.75 | |||||
| ROE % | 9.96 | |||||
| ROA % | 5.7 | |||||
| ROIC % | 7.49 | |||||
| ROC (Joel Greenblatt) % | 66.47 | |||||
| ROCE % | 7.78 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.34 | |||||
| Forward PE Ratio | 14.41 | |||||
| PE Ratio without NRI | 21.34 | |||||
| Shiller PE Ratio | 24.77 | |||||
| Price-to-Owner-Earnings | 20.39 | |||||
| PS Ratio | 3.58 | |||||
| PB Ratio | 2.08 | |||||
| Price-to-Free-Cash-Flow | 19.46 | |||||
| Price-to-Operating-Cash-Flow | 15.59 | |||||
| EV-to-EBIT | 19.68 | |||||
| EV-to-Forward-EBIT | 15.73 | |||||
| EV-to-EBITDA | 13.77 | |||||
| EV-to-Forward-EBITDA | 11.69 | |||||
| EV-to-Revenue | 3.99 | |||||
| EV-to-Forward-Revenue | 3.89 | |||||
| EV-to-FCF | 21.69 | |||||
| Price-to-Projected-FCF | 1.2 | |||||
| Price-to-Median-PS-Value | 0.88 | |||||
| Earnings Yield (Greenblatt) % | 5.08 | |||||
| Forward Rate of Return (Yacktman) % | 2.93 |
Guru Trades
See DetailsInsider Trades
See DetailsExecutives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 633,552.837 | ||
| EPS (TTM) (MXN) | 78.867 | ||
| Beta | 0.36 | ||
| Volatility % | 21.67 | ||
| 14-Day RSI | 5.76 | ||
| 14-Day ATR (MXN) | 15.091276 | ||
| 20-Day SMA (MXN) | 1802.123 | ||
| 12-1 Month Momentum % | -26.63 | ||
| 52-Week Range (MXN) | 1633.86 - 2599.68 | ||
| Shares Outstanding (Mil) | 1,329.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medtronic PLC Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||